Search Result "ShK"
Analogs of the Sea Anemone Potassium Channel Blocker ShK for the Treatment of Autoimmune Diseases
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 5 Year: 2011 Page: 313-321
Author(s): Christine Beeton, Michael W. Pennington, Raymond S. Norton
Excessive Oxidative Stress in the Synergistic Effects of Shikonin on the Hyperthermia-Induced Apoptosis
Journal: Current Molecular Medicine
Volume: 18 Issue: 5 Year: 2018 Page: 322-334
Author(s): J.-L. Piao,Y.-J. Jin,M.-L. Li,S.A. Zakki,L. Sun,Q.-W. Feng,D. Zhou,T. Kondo,Z.-G. Cui,H. Inadera
Potassium Channel Blockade by the Sea Anemone Toxin ShK for the Treatment of Multiple Sclerosis and Other Autoimmune Diseases
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2004 Page: 3041-3052
Author(s): Raymond S. Norton, Michael W. Pennington, Heike Wulff
MCDCalc: Markov Chain Molecular Descriptors Calculator for Medicinal Chemistry
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 4 Year: 2020 Page: 305-317
Author(s): Paula Carracedo-Reboredo,Ramiro Corona,Mikel Martinez-Nunes,Carlos Fernandez-Lozano,Georgia Tsiliki,Haralambos Sarimveis,Eider Aranzamendi,Sonia Arrasate,Nuria Sotomayor,Esther Lete,Cristian Robert Munteanu,Humbert González-DÃaz
Progress in Research of KV1.1 and KV1.3 Channels as Therapeutic Targets
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 16 Year: 2016 Page: 1877-1885
Author(s): Wei Zhao,Yuan Chen
Interactions of Cnidarian Toxins with the Immune System
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 5 Year: 2011 Page: 429-437
Author(s): Dusan Suput
Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 5 Year: 2012 Page: 661-674
Author(s): A. Felipe, J. Bielanska, N. Comes, A. Vallejo, S. Roig, S. Ramon y Cajal, E. Condom, J. Hernandez-Losa, J.C. Ferreres
Therapeutic Potential of Peptide Toxins that Target Ion Channels
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 5 Year: 2011 Page: 322-342
Author(s): Evelyne Beraud, K. George Chandy
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Journal: Current Alzheimer Research
Volume: 14 Issue: 3 Year: 2017 Page: 268-294
Author(s): Alexandre V. Ivachtchenko,Yan A. Ivanenkov,Mark S. Veselov,I. M. Okun
Novel Promising Therapeutic Agents in Multiple Sclerosis
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 1 Issue: 3 Year: 2007 Page: 218-224
Author(s): Abbas Mirshafiey